Previous Close | 2.72 |
1-Year Change | -80.57% |
6-Months Change | -74.95% |
3-Months Change | -46.56% |
Moving Avg (50d) | 4.6978 |
Moving Avg (200d) | 9.564 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 59.0M |
Beta (3-Years) | 1.94 |
Revenue Growth (ttm) | 59% |
Net Profit Margin (ttm) | -141.9% |
Return On Assets (ttm) | -95.46% |
EPS (ttm) | -137.98 |
PE Ratio (ttm) | -0.02 |
Dividend Yield | % |
Asset Description: | Agenus Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
2.617 | 2.537 | 2.483 | 2.403 | 2.27 | 2.136 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |